Global Highly Branched Cyclic Dextrin (HBCD) Market Growth 2026-2032
Description
The global Highly Branched Cyclic Dextrin (HBCD) market size is predicted to grow from US$ 18.15 million in 2025 to US$ 32.29 million in 2032; it is expected to grow at a CAGR of 8.7% from 2026 to 2032.
Global sales of Highly Branched Cyclic Dextrin (HBCD) was about 1867 tons in 2024 with average price of 6757 USD/ton.
Glico Nutrition is the first company to achieve commercial production of Highly Branched Cyclic Dextrin (HBCD) in the world.
The key raw materials are waxy corn starch and branching enzyme.
The average gross margin of the industry ranges from 28%-30%.
Highly Branched Cyclic Dextrin (HBCD), is a new type of dextrin that is produced from amylopectin via cyclization reaction of a branching enzyme (BE,1,4-α-D-glucan: 1,4-α-D-glucan 6-α-D-(1,4-α-D-glucano)-transferase,EC 2.4.1.18).
Highly Branched Cyclic Dextrin (HBCD), sits in a small but fast-growing niche of the global dextrin market. Technically, HBCD is produced from non-GMO waxy corn starch (amylopectin) via a proprietary enzymatic process involving branching/transglycosylation enzymes that restructure the starch into high-molecular-weight, highly branched cyclic clusters. This architecture gives solutions very low osmolality, high solubility and rapid gastric emptying, so relatively large carbohydrate doses can be delivered with less gastrointestinal distress than glucose or standard maltodextrin – a key selling point in endurance and high-intensity sports nutrition. Beyond sports supplements, FDA-notified GRAS status for “cyclic dextrin, highly branched” allows its use as a carbohydrate source, flavouring aid and spray-drying carrier across a wide range of food categories at 0.25–24 g per serving, including beverages, cereals, dairy, snacks and powdered soups.
On the supply side, the industry is unusually concentrated and technology-driven. Ezaki Glico / Glico Nutrition developed Highly Branched Cyclic Dextrin (HBCD) in Japan and has marketed it as a food ingredient since 2002; the company later secured FDA notified GRAS status (2012) and has built strong IP and scientific data around performance benefits. In parallel, ZymeBase based in China has emerged as a second major technology holder with SusCarb® Dextrin, another patented HBCD positioned as a “new era sports energy” ingredient and winner of multiple innovation awards in sports-nutrition forums in 2024–2025. Upstream, the cost structure is dominated by waxy corn starch and food-grade enzymes; the FDA’s separate GRAS notice for a 1,4-α-D-glucan branching enzyme from Ezaki Glico explicitly identifies its intended use in producing modified starches including highly branched cyclic dextrins, underscoring the tight coupling between enzyme technology and HBCD manufacturing capacity.
For consumption regions, USA, Japan and China are the key consumers. USA depends on imported Highly Branched Cyclic Dextrin (HBCD) from Japan to meet its own demand. Chinese Highly Branched Cyclic Dextrin (HBCD) output keeps increasing and the country has greatest market potential for the product.
The regulatory and quality landscape is supportive but contributes to entry barriers. For the US, FDA GRAS notifications cover both highly branched cyclic dextrin as a food ingredient and the branching enzyme preparation used to manufacture it, specifying food categories and use levels and confirming safety under intended conditions of use. In addition, major HBCD brands emphasize non-GMO corn sourcing, and frequently obtain regional certifications and innovation awards that reinforce their credibility with brand owners and formulators. At the same time, the need for robust safety dossiers, enzyme-production controls and international food-law compliance has discouraged small commodity starch players from quickly cloning the technology, helping preserve the market’s premium structure.
LP Information, Inc. (LPI) ' newest research report, the “Highly Branched Cyclic Dextrin (HBCD) Industry Forecast” looks at past sales and reviews total world Highly Branched Cyclic Dextrin (HBCD) sales in 2025, providing a comprehensive analysis by region and market sector of projected Highly Branched Cyclic Dextrin (HBCD) sales for 2026 through 2032. With Highly Branched Cyclic Dextrin (HBCD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Highly Branched Cyclic Dextrin (HBCD) industry.
This Insight Report provides a comprehensive analysis of the global Highly Branched Cyclic Dextrin (HBCD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Highly Branched Cyclic Dextrin (HBCD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Highly Branched Cyclic Dextrin (HBCD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Highly Branched Cyclic Dextrin (HBCD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Highly Branched Cyclic Dextrin (HBCD).
This report presents a comprehensive overview, market shares, and growth opportunities of Highly Branched Cyclic Dextrin (HBCD) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Other
Segmentation by Application:
Sport Supplements
Cosmetics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Glico Nutrition
Zymebase
Key Questions Addressed in this Report
What is the 10-year outlook for the global Highly Branched Cyclic Dextrin (HBCD) market?
What factors are driving Highly Branched Cyclic Dextrin (HBCD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Highly Branched Cyclic Dextrin (HBCD) market opportunities vary by end market size?
How does Highly Branched Cyclic Dextrin (HBCD) break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Global sales of Highly Branched Cyclic Dextrin (HBCD) was about 1867 tons in 2024 with average price of 6757 USD/ton.
Glico Nutrition is the first company to achieve commercial production of Highly Branched Cyclic Dextrin (HBCD) in the world.
The key raw materials are waxy corn starch and branching enzyme.
The average gross margin of the industry ranges from 28%-30%.
Highly Branched Cyclic Dextrin (HBCD), is a new type of dextrin that is produced from amylopectin via cyclization reaction of a branching enzyme (BE,1,4-α-D-glucan: 1,4-α-D-glucan 6-α-D-(1,4-α-D-glucano)-transferase,EC 2.4.1.18).
Highly Branched Cyclic Dextrin (HBCD), sits in a small but fast-growing niche of the global dextrin market. Technically, HBCD is produced from non-GMO waxy corn starch (amylopectin) via a proprietary enzymatic process involving branching/transglycosylation enzymes that restructure the starch into high-molecular-weight, highly branched cyclic clusters. This architecture gives solutions very low osmolality, high solubility and rapid gastric emptying, so relatively large carbohydrate doses can be delivered with less gastrointestinal distress than glucose or standard maltodextrin – a key selling point in endurance and high-intensity sports nutrition. Beyond sports supplements, FDA-notified GRAS status for “cyclic dextrin, highly branched” allows its use as a carbohydrate source, flavouring aid and spray-drying carrier across a wide range of food categories at 0.25–24 g per serving, including beverages, cereals, dairy, snacks and powdered soups.
On the supply side, the industry is unusually concentrated and technology-driven. Ezaki Glico / Glico Nutrition developed Highly Branched Cyclic Dextrin (HBCD) in Japan and has marketed it as a food ingredient since 2002; the company later secured FDA notified GRAS status (2012) and has built strong IP and scientific data around performance benefits. In parallel, ZymeBase based in China has emerged as a second major technology holder with SusCarb® Dextrin, another patented HBCD positioned as a “new era sports energy” ingredient and winner of multiple innovation awards in sports-nutrition forums in 2024–2025. Upstream, the cost structure is dominated by waxy corn starch and food-grade enzymes; the FDA’s separate GRAS notice for a 1,4-α-D-glucan branching enzyme from Ezaki Glico explicitly identifies its intended use in producing modified starches including highly branched cyclic dextrins, underscoring the tight coupling between enzyme technology and HBCD manufacturing capacity.
For consumption regions, USA, Japan and China are the key consumers. USA depends on imported Highly Branched Cyclic Dextrin (HBCD) from Japan to meet its own demand. Chinese Highly Branched Cyclic Dextrin (HBCD) output keeps increasing and the country has greatest market potential for the product.
The regulatory and quality landscape is supportive but contributes to entry barriers. For the US, FDA GRAS notifications cover both highly branched cyclic dextrin as a food ingredient and the branching enzyme preparation used to manufacture it, specifying food categories and use levels and confirming safety under intended conditions of use. In addition, major HBCD brands emphasize non-GMO corn sourcing, and frequently obtain regional certifications and innovation awards that reinforce their credibility with brand owners and formulators. At the same time, the need for robust safety dossiers, enzyme-production controls and international food-law compliance has discouraged small commodity starch players from quickly cloning the technology, helping preserve the market’s premium structure.
LP Information, Inc. (LPI) ' newest research report, the “Highly Branched Cyclic Dextrin (HBCD) Industry Forecast” looks at past sales and reviews total world Highly Branched Cyclic Dextrin (HBCD) sales in 2025, providing a comprehensive analysis by region and market sector of projected Highly Branched Cyclic Dextrin (HBCD) sales for 2026 through 2032. With Highly Branched Cyclic Dextrin (HBCD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Highly Branched Cyclic Dextrin (HBCD) industry.
This Insight Report provides a comprehensive analysis of the global Highly Branched Cyclic Dextrin (HBCD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Highly Branched Cyclic Dextrin (HBCD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Highly Branched Cyclic Dextrin (HBCD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Highly Branched Cyclic Dextrin (HBCD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Highly Branched Cyclic Dextrin (HBCD).
This report presents a comprehensive overview, market shares, and growth opportunities of Highly Branched Cyclic Dextrin (HBCD) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Other
Segmentation by Application:
Sport Supplements
Cosmetics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Glico Nutrition
Zymebase
Key Questions Addressed in this Report
What is the 10-year outlook for the global Highly Branched Cyclic Dextrin (HBCD) market?
What factors are driving Highly Branched Cyclic Dextrin (HBCD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Highly Branched Cyclic Dextrin (HBCD) market opportunities vary by end market size?
How does Highly Branched Cyclic Dextrin (HBCD) break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
78 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Highly Branched Cyclic Dextrin (HBCD) by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Highly Branched Cyclic Dextrin (HBCD) by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
